Therapeutic Strategies for Hereditary Kidney Cancer.

about

Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models.Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management.

P2860

Q41472778-4EA36A86-5C4D-4C3F-99FC-B39121790291 Q55083786-7D27F05B-8BD2-4489-9E38-6B42739E89E1

P2860

Therapeutic Strategies for Hereditary Kidney Cancer.

Item

http://www.wikidata.org/entity/Q38871343

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Therapeutic Strategies for Hereditary Kidney Cancer.

@en

type

Item

label

Therapeutic Strategies for Hereditary Kidney Cancer.

@en

prefLabel

Therapeutic Strategies for Hereditary Kidney Cancer.

@en

P1476

Therapeutic Strategies for Hereditary Kidney Cancer.

@en

P2093

Abhinav Sidana

http://www.w3.org/2001/XMLSchema#string

Ramaprasad Srinivasan

http://www.w3.org/2001/XMLSchema#string

P2860

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Inhibition of transcription elongation by the VHL tumor suppressor protein

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C

Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America

Metabolism of kidney cancer: from the lab to clinical practice

Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma

Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome

Targeting the c-Met signaling pathway in cancer

Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease

Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys

P2888

s11912-016-0537-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-016-0537-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1025363646

http://www.w3.org/2001/XMLSchema#string

P698

27325049

http://www.w3.org/2001/XMLSchema#string

Therapeutic Strategies for Hereditary Kidney Cancer.

about

P2860

P2860

Therapeutic Strategies for Hereditary Kidney Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698